moa glp 1 Mechanism of action of GLP-1 [25] Mechanisms of GLP-1 Receptor Agonists

These central effects translate into substantial weight loss - typically 5%-15% of body weight with current GLP-1 RAs - which directly ameliorates hepatic steatosis by reducing adipose tissue mass, reducing hepatic free fatty acid influx, and improving insulin sensitivity

What actually happens when you stop taking GLP-1 This is the section nobody wants to read

doi:10.1038/s41598-017-03873-9 52

From 2016 to 2020, the compound annual growth rate of long-acting GLP-1 agonists was as high as 50.1%, much higher than the 5.6% for short-acting GLP-1 agonists

This means your doctor may recommend a medicine for a condition it hasnt been approved by the FDA to treat